Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,580 | -60,080 | -26,554 | -13,209 | N/A |
| Depreciation Amortization | 2,026 | 880 | 225 | 116 | N/A |
| Accounts receivable | -4,693 | -1,670 | -1,098 | 204 | N/A |
| Accounts payable and accrued liabilities | 4,737 | -1,110 | 661 | -2,909 | N/A |
| Other Working Capital | 11,778 | 1,607 | 1,121 | -3,583 | N/A |
| Other Operating Activity | 7,386 | 4,094 | 982 | 3,294 | 0 |
| Operating Cash Flow | $-104,346 | $-56,279 | $-24,663 | $-16,087 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,276 | -66,751 | 0 | N/A | N/A |
| PPE Investments | -1,107 | -1,510 | -700 | -35 | N/A |
| Investing Cash Flow | $-2,383 | $-68,261 | $-700 | $-35 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,000 | 35,000 | 0 | N/A | N/A |
| Debt Repayment | -35,000 | N/A | N/A | -32 | N/A |
| Common Stock Issued | 684 | 227 | 159 | 22 | N/A |
| Other Financing Activity | 54,846 | 92,984 | 34,980 | 3,914 | 0 |
| Financing Cash Flow | $80,530 | $128,211 | $35,139 | $3,904 | $N/A |
| Exchange Rate Effect | 2 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 45,716 | 42,045 | 32,269 | 44,487 | N/A |
| End Cash Position | 19,519 | 45,716 | 42,045 | 32,269 | N/A |
| Net Cash Flow | $-26,197 | $3,671 | $9,776 | $-12,218 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -104,346 | -56,279 | -24,663 | -16,087 | N/A |
| Capital Expenditure | -1,107 | -1,510 | -700 | -35 | N/A |
| Free Cash Flow | -105,453 | -57,789 | -25,363 | -16,122 | 0 |